Millions of senior Americans are seeing their drug costs skyrocket after maxing out their early coverage, the Washington Post reported.
The gap in insurance, popularly called the donut hole, is a provision in most of the private plans offered in Medicare's new Part D prescription drug program, the newspaper said.
Under a standard plan this year, Medicare handles 75 percent of drug costs after a deductible until the bill reaches $2,250. Coverage does not kick in again until those costs total $5,100.
The very poor, however, are eligible for special subsidies.
The Congressional Budget Office and the Kaiser Family Foundation projected that about 7 million recipients would be affected by the donut hole this year, the newspaper said.
Copyright 2006 by United Press International
Related stories:
Cervical cancer shots less cost-effective with age
(AP) -- An expensive vaccine aimed at preventing cervical cancer makes sense for young teens when it comes to cost-effectiveness, but not for women in their 20s, contends a new report.
Researchers discover how rheumatoid arthritis causes bone loss
Researchers have discovered key details of how rheumatoid arthritis (RA) destroys bone, according to a study published in the Aug. 22 edition of the
Journal of Biological Chemistry. The findings are already guiding attempts to design new drugs to reverse RA-related bone loss and may also address more common forms of osteoporosis with a few adjustments.
Aspirin, acid blocker a-day keeps GI bleeding
For patients with clogged heart arteries who take long-term, low-dose aspirin to prevent a cardiac event, adding a stomach acid-blocking drug to their daily routine has been shown to reduce their risk for upper gastrointestinal bleeding – an infrequent, but serious side-effect of regular aspirin use.
Gift cards key to new AIDS prevention strategy
(AP) -- Could the AIDS virus be stopped with gift cards? Desperate for a way to stop the escalating spread of HIV among young gay men, public health officials are looking to novel strategies, such as enlisting local gay opinion leaders to urge their peers to practice safe sex.
Scientists create 20 disease-specific stem cell lines
(PhysOrg.com) -- Harvard Stem Cell Institute researcher George Q. Daley, associate director of the Stem Cell Program at Children's Hospital Boston, has with HSCI colleagues Chad Cowan and Konrad Hochedlinger of Massachusetts General Hospital produced a robust new collection of disease-specific stem cell lines, all of which were developed using the new induced pluripotent stem cell (iPS) technique. The work is described in a paper published in today's online edition of the journal
Cell.
Researchers demonstrate activity of mebendazole in metastatic melanoma
Researchers at the NYU Cancer Institute and the Ronald O. Perelman Department of Dermatology have identified mebendazole, a drug used globally to treat parasitic infections, as a novel investigational agent for the treatment of chemotherapy-resistant malignant melanoma.
Medicare Modernization Act not associated with major changes in access to chemotherapy
Despite concerns that reductions in physician reimbursements for outpatient chemotherapy related drugs as a result of the Medicare Modernization Act of 2003 would have a detrimental effect on patients requiring chemotherapy, new research indicates that there have not been major changes in travel distance and patient wait times for chemotherapy in the Medicare population since 2003, according to a study in the July 9 issue of
JAMA.
Members of consumer-driven health plans choosing less care
Consumer-driven health plans (CDHP) -- hailed since their inception in 2000 as a tool to help control costs -- are resulting in members forgoing care and discontinuing drugs to treat chronic medical problems, according to two newly published studies.